INTRODUCTION AND OBJECTIVES: Prostate cancer (PC)
is the most common non-cutaneous cancer in men and a leading cause of cancer death. In the US, black men are disproportionately affected with higher incidence of and mortality to PC than any other race. We hypothesize that different inflammatory cells may stimulate or inhibit PC development, and that black men have more pro-tumor inflammation contributing to the health disparity seen in PC in the US.
METHODS: Prostate biopsies were obtained from 84 men, 50% black/50% white men, with and without PC on biopsy. Using fluorescence microscopy with multiplex immunohistochemistry, biopsy tissue samples were stained for 4 T-cell markers (CD3, CD4, CD8, and FOXP3) and 3 regions were examined (prostate tumor, tumor-free areas surrounding the tumor, and controls or biopsy negative samples). Using T-tests, data were analyzed for type of cell (marker) and cells/mm2 by region. Analyses were stratified by race. An alpha of 0.0125 (after Bonferroni correction p[0.05/4) was used.
RESULTS: Prostate biopsies of black and white men showed several significant differences. Prostate biopsies in black men had statistically significant higher levels of CD8 T-cell expression compared to those of white men (p[8.9x10-8) . Black men prostate biopsy tissues displayed higher levels of all markers studied.
CONCLUSIONS: Prostate biopsies showed statistically significant differences in T-cell markers, particularly when we compared between the tumor-free region surrounding PC in black men against all 3 regions in white men. These data suggest black men have higher expression of T-cells surrounding PC regions, generating a pro-tumor inflammatory micro-environment, which may in part contribute to PC racial disparity. 
MP28-07 DEVELOPMENT AND VALIDATION OF LNCRNASeBASED NOMOGRAM FOR PREDICTION OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER BY BIOINFORMATICS ANALYSIS
Ning Shao*, Yuan Qu, Fang Wan, Ding Ye, shanghai, China, People's Republic of INTRODUCTION AND OBJECTIVES: Early biochemical recurrence (BCR) was considered as a sign for clinical recurrence and metastasis of prostate cancer (PCa). The purpose of the present study was to identify a lncRNA-based nomogram that can predict BCR of PCa accurately.
METHODS: Bioinformatics analysis, such as propensity score matching (PSM) and differentially expressed genes (DEGs) analyses were used to identify candidate lncRNAs for further bioinformatics analysis. LASSO Cox regression model was used to select the most significant prognostic lncRNAs and construct the lncRNAs signature for predicting BCR in discovery set. Additionally, a nomogram based on our lncRNAs signature was also formulated. Both lncRNAs signature and nomogram were validated in test set. GSEA was carried out to identify various lncRNAs sets which share a common biological function, chromosomal location, or regulation.
RESULTS: A total of 457 patients with sufficient BCR information were included in our analysis. Finally, a five lncRNAs signature significantly associated with BCR was identified in discovery set (HR[0.44, and validated in test set (HR[0.22, . Additionally, the lncRNAs-based nomogram showed significant performance for predicting BCR in both discovery set (C-index [ 0.74) and test set (C-index [ 0.78).
CONCLUSIONS: In conclusion, our lncRNAs-based nomogram is a reliable prognostic tool for BCR in PCa patients. In addition, the present study put forward the direction for the further investigation on the mechanism of PCa progression. Vol. 201, No. 4S, Supplement, Saturday, May 4, 2019 THE JOURNAL OF UROLOGY Ò e405
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